Clinical Trial

Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial

Study acronym: TPAC

Active, Not Recruiting Phase 3

Record status

This record was last updated December 16, 2024 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.

Summary

This study will compare the effectiveness of combined parental stimulant medication and behavioral parent training (BPT) versus BPT alone on child ADHD-related impairment (primary outcome), child ADHD and externalizing symptoms, time to child stimulant prescription (secondary child outcomes) and parental ADHD impairment, parental ADHD symptoms, parenting, and BPT engagement (parental outcomes/target mechanisms). This study will also assess the care delivery context and develop an implementation approach for treatment of families with a parent with ADHD and a child with elevated ADHD symptoms via telehealth in primary care sites providing pediatric care.

Protocol Amendment History 8 amendments

This ClinicalTrials.gov record has been amended 8 times since 2020-01-21; most recent amendment 2026-05-30.

Status change: Active, Not Recruiting → Completed 2026-05-30

Status change: Recruiting → Active, Not Recruiting 2024-12-10

Status change: Not Yet Recruiting → Recruiting 2020-11-03

Trial Details

NCT Number	NCT04240756
Lead Sponsor	University of Maryland, College Park Collaborators: Children's National Research Institute, University of Michigan, Seattle Children's Hospital, National Institute of Mental Health (NIMH)
Conditions	ADHD, Parenting
Enrollment	240 participants
Start Date	2020-08-06
Primary Completion	2025-05-30 (estimated)
Study Completion	2025-07-31 (estimated)
Updated on ClinicalTrials.gov	2024-12-16